Table 2.
Clinical course and outcomes in different oxLDL level decrease groups.
| Δtertile 1(mild decrease) | Δtertile 2 (moderate decrease) | Δtertile 3(significant decrease) | p value | |
|---|---|---|---|---|
| Δ < 36.23 pg/mL | Δ: 36.23 pg/mL-60.63 pg/mL | Δ ≥ 60.64 pg/mL | ||
| NIHSS score at admission (median) | 6 (2.5, 8.5) | 4 (2, 5) | 3(2, 4) | <0.01 |
| Neurological impairment severity at admission | <0.01 | |||
| Mild, NIHSS score ≤ 4 | 23 (33.33) | 28 (40.58) | 40 (57.97) | |
| Moderate, NIHSS scores 5-9 | 20 (28.99) | 35 (50.72) | 19 (27.54) | |
| Severe, NIHSS score ≥ 10 | 26 (37.68) | 6 (8.70) | 10 (14.49) | |
| DWI volumes (cm3) | 4.21 (1.17, 9.58) | 3.08 (1.27, 4.73) | 2.38 (1.59, 8.68) | 0.41 |
| Median onset-to-MRI time (hour) | 74.20 (52.05, 99.00) | 68.50 (45.75, 88.75) | 66.00 (32.25, 97.00) | 0.49 |
| Clinical response at discharge | <0.01 | |||
| Neurological improvement | 10 (14.49) | 29 (42.03) | 38 (55.07) | |
| No significant neurological change | 27 (39.13) | 23 (33.33) | 20 (28.99) | |
| Neurologic worsening | 32 (46.38) | 17 (24.64) | 11 (15.94) | |
| Favorable functional prognosis | 38 (55.07) | 58 (84.06) | 63 (91.30) | <0.01 |